JP2022550901A5 - - Google Patents
Info
- Publication number
- JP2022550901A5 JP2022550901A5 JP2022520803A JP2022520803A JP2022550901A5 JP 2022550901 A5 JP2022550901 A5 JP 2022550901A5 JP 2022520803 A JP2022520803 A JP 2022520803A JP 2022520803 A JP2022520803 A JP 2022520803A JP 2022550901 A5 JP2022550901 A5 JP 2022550901A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- nucleic acid
- sirna
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962910760P | 2019-10-04 | 2019-10-04 | |
| US62/910,760 | 2019-10-04 | ||
| US201962915450P | 2019-10-15 | 2019-10-15 | |
| US62/915,450 | 2019-10-15 | ||
| PCT/US2020/054251 WO2021067930A1 (en) | 2019-10-04 | 2020-10-05 | Tumor-targeting polypeptide nanoparticle delivery system for nucleic acid therapeutics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022550901A JP2022550901A (ja) | 2022-12-05 |
| JP2022550901A5 true JP2022550901A5 (cg-RX-API-DMAC7.html) | 2023-10-16 |
| JP7644105B2 JP7644105B2 (ja) | 2025-03-11 |
Family
ID=75337467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520803A Active JP7644105B2 (ja) | 2019-10-04 | 2020-10-05 | 核酸治療薬のための腫瘍標的化ポリペプチドナノ粒子送達システム |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220331441A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4037716A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7644105B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220110174A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115151278B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020357078A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022006473A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3156823A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291916A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021067930A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202204734B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7512207B2 (ja) * | 2018-05-24 | 2024-07-08 | サーナオミクス インコーポレイテッド | 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法 |
| CN118613484A (zh) * | 2021-12-30 | 2024-09-06 | 拜奥迪斯私人有限公司 | 抗叶酸剂接头-药物和抗体-药物缀合物 |
| CN120158469A (zh) * | 2025-05-19 | 2025-06-17 | 内蒙古大学 | 一种灌胃递送靶向编辑甲烷八叠球菌的牛甲烷减排方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10501963A (ja) * | 1994-04-15 | 1998-02-24 | ターゲテッド ジェネティクス コーポレイション | 遺伝子送達融合タンパク質 |
| EP1817416A2 (en) * | 2004-11-05 | 2007-08-15 | Intradigm Corporation | Compositions for treating respiratory viral infections and their use |
| EP1812016A4 (en) * | 2004-11-17 | 2010-07-14 | Univ Maryland | HIGH-BRANCHED HK-PEPTIDES AS EFFECTIVE CARRIER FROM SIRNA |
| ES2545963T3 (es) * | 2007-11-06 | 2015-09-17 | Sirnaomics, Inc. | Terapéutica con ARNi multidirigidos para la cicatrización de heridas de la piel sin cicatriz |
| CN102316858A (zh) * | 2008-02-26 | 2012-01-11 | 阿帕玛生物科技公司 | 修饰过的可调的纳米粒子用于传递治疗,诊断,实验化合物及相关成分用于治疗用药 |
| WO2010078517A2 (en) | 2008-12-31 | 2010-07-08 | Sirnaomics, Inc. | Compositions and methods using sirna molecules and sirna cocktails for the treatment of breast cancer |
| WO2011011631A2 (en) * | 2009-07-22 | 2011-01-27 | Samuel Zalipsky | Nucleic acid delivery vehicles |
| US11058779B2 (en) * | 2015-09-08 | 2021-07-13 | Sirnaomics, Inc. | Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection |
| CN107793388B (zh) * | 2016-10-14 | 2021-06-11 | 长沙天赐生物医药科技有限公司 | 平板霉素类似物及其制备方法和应用 |
| EP3532071A4 (en) * | 2016-10-30 | 2020-09-02 | Sirnaomics, Inc. | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE TO ACTIVATE HUMAN FIBROBLAST AND MYOFIBROBLAST APOPTOSIS |
| JP7512207B2 (ja) | 2018-05-24 | 2024-07-08 | サーナオミクス インコーポレイテッド | 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法 |
| US20210180089A1 (en) * | 2018-08-14 | 2021-06-17 | Loxegen Holdings Pty Ltd | Nanoparticles for transfection |
| WO2021061437A1 (en) | 2019-09-12 | 2021-04-01 | Sirnaomics, Inc. | CO-DELIVERY OF TGF-β SIRNA AND PDL1 SIRNA TO TREAT CANCER |
-
2020
- 2020-10-05 KR KR1020227014303A patent/KR20220110174A/ko not_active Ceased
- 2020-10-05 IL IL291916A patent/IL291916A/en unknown
- 2020-10-05 JP JP2022520803A patent/JP7644105B2/ja active Active
- 2020-10-05 CN CN202080084185.2A patent/CN115151278B/zh active Active
- 2020-10-05 CA CA3156823A patent/CA3156823A1/en active Pending
- 2020-10-05 WO PCT/US2020/054251 patent/WO2021067930A1/en not_active Ceased
- 2020-10-05 EP EP20872228.0A patent/EP4037716A4/en not_active Withdrawn
- 2020-10-05 BR BR112022006473A patent/BR112022006473A2/pt not_active IP Right Cessation
- 2020-10-05 AU AU2020357078A patent/AU2020357078A1/en not_active Abandoned
-
2022
- 2022-04-04 US US17/713,037 patent/US20220331441A1/en active Pending
- 2022-04-28 ZA ZA2022/04734A patent/ZA202204734B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gooding et al. | Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis | |
| CN112370532B (zh) | 作为转染试剂的羧化多胺衍生物 | |
| Uritu et al. | Hybrid fullerene conjugates as vectors for DNA cell-delivery | |
| EP1981543A1 (en) | Chemically modified polycation polymer for sirna delivery | |
| JP7708728B2 (ja) | カチオン性粘液酸ポリマー系デリバリーシステム | |
| EP2903652A1 (en) | Hydroxylated polyamine derivatives as transfection reagents | |
| US20220331441A1 (en) | Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics | |
| US12054714B2 (en) | Peptide docking vehicle for targeted nucleic acid delivery | |
| CN115244064A (zh) | 治疗性分子的靶向递送 | |
| CN111218443B (zh) | 合成核酸药物偶联物的方法 | |
| CN106397765A (zh) | 维生素e修饰的聚乙烯亚胺衍生物及其合成方法和应用 | |
| JP2003503569A (ja) | 核酸を細胞に輸送するためのコポリマー | |
| WO2008048079A1 (en) | Long acting formulation of biopharmaceutical | |
| EP3507309B1 (en) | Capped cyclodextrin-hydrophobic moiety conjugate, cyclodextrin supramolecular polymer, and cyclodextrin si-rna complex and method of synthesis thereof | |
| KR102823910B1 (ko) | 바이오 약물의 경구전달용 덴드리머 구조 흡수 증진제 | |
| US20250263694A1 (en) | Conjugated composition and method for delivering a therapeutic nucleic acid sequence to a living cell | |
| WO2025238236A1 (en) | Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol | |
| KR100346577B1 (ko) | 간세포 특이적인 담체 및 이의 dna와의 복합체 | |
| Deng et al. | MC8 peptide-mediated Her-2 receptor targeting based on PEI-β-CyD as gene delivery vector | |
| KR20250028446A (ko) | 세포내 전달을 위한 펩타이드 | |
| US20100261245A1 (en) | Long acting formulation of biopharmaceutical | |
| KR20240099391A (ko) | 폴리에틸렌이민 및 폴리에틸렌 글리콜을 포함하는 표적화된 선형의 컨쥬게이트 및 이를 포함하는 다중복합체 | |
| WO2026016810A1 (zh) | 抗体寡核苷酸缀合物及其用途 | |
| Simpson | Synthesis, Characterization, and Assessment of Cationic Polypeptoids Toward Gene Delivery and Development of Air Stable N-Substituted N-Thiocarboxyanhydrides | |
| Baumhover | The synthesis and development of novel multi-component polyacridine gene delivery systems |